Associated Papers
GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients.
Zaki-Dizaji M et al.
Brain, Behavior, & Immunity - Health, 2024
Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders.
Parent HH et al.
Molecular Pharmacology, 2024
Identification of Neurotransmission and Synaptic Biological Processes Disrupted in Autism Spectrum Disorder Using Interaction Networks and Community Detection Analysis.
Vilela J et al.
Biomedicines, 2023
38001974 (PubMed )
Supplement: biomedicines-11-02971-s001.zip › Supplementary_Table_S5.xlsx › S5
GRM7 gene mutations and consequences for neurodevelopment.
Freitas GA et al.
Pharmacology, Biochemistry, and Behavior, 2023
Integrative analysis prioritised oxytocin-related biomarkers associated with the aetiology of autism spectrum disorder.
Wang T et al.
Ebiomedicine, 2022
35665681 (PubMed )
Supplement: mmc24.xlsx › Sheet1
Pathogenic GRM7 Mutations Associated with Neurodevelopmental Disorders Impair Axon Outgrowth and Presynaptic Terminal Development.
Song JM et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2021
Systematic reconstruction of autism biology from massive genetic mutation profiles.
Luo W et al.
Science Advances, 2018
29651456 (PubMed )
Supplement: 1701799_TableS5.xlsx › missense
Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.
Fisher NM et al.
Frontiers in Molecular Neuroscience, 2018
Select a paper to view details